|
|
Books > Medicine > Clinical & internal medicine > Diseases & disorders > General
This book is an amalgamation of knowledge, experience, and
expertise in various aspects of nanotechnology, by experts who are
proficient in designing of novel nanoformulations that are used in
the treatment of various challenging and prevalent diseases. It is
an exhaustive compilation of the multi-faceted arena of
nanoformulations and the healthcare system that caters to the needs
of academicians, scholars, researchers etc. The most important
aspect of the book covers various types of nanoformulations and
their applications in treatment of communicable and
non-communicable diseases. Each chapter focuses on a particular
nanoformulation as well as a disease including the pathophysiology
of the disease, the current treatment modalities of diseases, the
role of nanoformulation in treatment and other future aspects and
directions for further work. Coverage includes neuropathic pain,
colon targeting, nose-to-brain drug delivery, skin cancer,
arthritis and tuberculosis.
Manifesting Happy is a journey of self-care for educators. The book
is recognition of the essential capacity that educators fulfill
each and every day. By combining two foundational theories, the
dimensions of wellness and applied behavior analysis, readers will
create a comprehensive self-care plan by which they can manifest a
stronger sense of self and well-being. The book provides an
overview of the eight dimensions of wellness and introduces
opportunities to gain a better sense of holistic balance. Readers
will be exposed to the science of behavior analysis and the
benefits of grounding wellness to the scientific principle of the
functions of behavior. Through an easy to follow four step planning
process of Discover, Define, Design, and Do educators can create a
self-care plan that will help them to manifest their happy in order
to best support students in the classroom. The book also includes
self-care strategies to practice and even ideas to implement with
students.
The disorders induced by iodine deficiency affect at least one
billion people. Because ofits effects on brain development,
iodinedeficiency is the single most preventable cause of mental
retardation in the world. Therefore, the United Nations and the
Heads of State of almost all the world's countries represented at
the Summit for Children in 1990 adopted resolutions to eradicate
the disorders induced by iodine deficiency (IDD) by the year 2000.
For geological and socio-economic reasons, most of the populations
affected by iodine deficiency disorders live in isolated and
usually mountainous areas, in pre industrialized parts ofthe world.
The problem of iodine deficiency in Europe has been greatly
underestimated in the last decades. After the remarkable studies on
the effects of iodine deficiency and their prevention and
correction in Switzerland, IDD was generally considered no longer a
significant public health problem in Europe. However, surveys
carried out in the early 1980's under the auspices of the European
Thyroid Association, clearly demonstrated the persistence of
moderately or even severely affected areas. These surveys also
highlighted the lack ofinformation about large parts ofEurope,
especially its eastern part. It is only quite recently, following
major changes in international relations and thanks to the support
of UNICEF, WHO, the International Council for the Control of Iodine
Deficiency Disorders and the European Thyroid Association, that
more extensive surveys have been conducted in several parts of
Europe hitherto almost unexplored. These surveys showed that most
European countries were iodine deficient."
Respiratory function is a major determinant of the overall quality
of health and well-being of an individual. This book runs the gamut
of chapters devoted to chronic cough-related conditions in children
and adults, health care quality and safety, environmental pollution
health effects, efficiency of therapeutic approaches and a mutual
dependence of respiratory and non-respiratory illnesses. An
integrated approach to the investigation and treatment of sleep
disordered breathing as well as the use of new and more efficient
diagnostic strategies for pleural tuberculosis are presented.
Chapters focus on translating science into practice, with an eye on
presymptomatic identification of serious ailments for which there
could be more effective therapy, leading to improved general health
outcomes. This book includes chapters about disorders which will be
of interest to clinicians, family practitioners and medical
researchers.
William H. Foege, one of the most respected leaders in global
public health, takes readers on a tour of his time at the CDC. In
its seventy years, the Centers for Disease Control and Prevention
(CDC) has evolved from a malaria control program to an institution
dedicated to improving health for all people across the world. The
Fears of the Rich, The Needs of the Poor is a revealing account of
the CDC's development by its former director, public health
luminary William H. Foege. Dr. Foege tells the stories of pivotal
moments in public health, including the eradication of smallpox
(made possible due in part to Foege's research) and the discovery
of Legionnaires' disease, Reye syndrome, toxic shock syndrome, and
HIV/AIDS. With good humor and optimism, he recounts the various
crises he surmounted, from threats of terrorist attacks to
contentious congressional hearings and funding cuts. Highlighting
the people who made possible some of public health's biggest
successes, Foege outlines the work required behind the scenes and
describes the occasional tensions between professionals in the
field and the politicians in charge of oversight. In recent years,
global public health initiatives have come from unanticipated
sources. Giants in the field now include President Jimmy Carter and
his wife, Rosalynn, who promote programs aimed at neglected
diseases. Melinda and Bill Gates have invigorated the field through
research and direct program support, especially in the area of
vaccine-preventable diseases. And the Merck Mectizan program has
dramatically reduced river blindness in Africa. Foege has been
involved in all of these efforts, among others, and he brings to
this book the knowledge and wisdom derived from a long and
accomplished career. The Fears of the Rich, The Needs of the Poor
is an inviting but unvarnished account of that career and offers a
plethora of lessons for those interested in public health.
This up-to-date reference book discusses the synthesis, production,
and application of various microbial enzymes and metabolites for
health. Microorganisms like bacteria (lactic acid bacteria,
Bacillus species), yeasts, and filamentous fungi have been globally
exploited for their biotechnological applications. This book
discusses ways to use them commercially. Chapters include the
production of fibrinolytic enzymes, microbial lipases, bacteriocin
production by lactic acid bacteria, and bioactives produced. It
also covers microbial synthesis of alkaloids, terpenoids, and
steroids. The book is useful for researchers, academicians, and
industry experts in microbiology and biotechnology.
This up-to-date reference book compiles the recent developments,
innovations, and perspectives on second and third-generation
bioplastics. It discusses the main commercialized bioplastics, such
as polylactic acid (PLA) and polyhydroxyalkanoates (PHAs). Chapters
include the use of alternative raw materials and innovations in
bioplastic production processes to reduce costs and decrease
environmental impacts. It covers bioplastic production from
lignocellulosic biomass, sugars, or oils produced by microbes and
municipal waste material. It also includes techno-economic aspects.
The book is meant for researchers and industry experts in
biotechnology, environmental sciences, and applied microbiology.
Challenging the concept that since the discovery of the plague
bacillus in 1894 the study of the disease was dominated by
bacteriology, Ethnographic Plague argues for the role of
ethnography as a vital contributor to the configuration of plague
at the turn of the nineteenth century. With a focus on research on
the Chinese-Russian frontier, where a series of pneumonic plague
epidemics shook the Chinese, Russian and Japanese Empires, this
book examines how native Mongols and Buryats came to be understood
as holding a traditional knowledge of the disease. Exploring the
forging and consequences of this alluring theory, this book seeks
to understand medical fascination with culture, so as to underline
the limitations of the employment of the latter as an explanatory
category in the context of infectious disease epidemics, such as
the recent SARS and Ebola outbreaks.
Smallpox, yellow fever, malaria, and polio, fearful diseases that
once beset Americans, are now largely, just unhappy history. Yet
from our confrontations with these past plagues come lessons that
inform today's struggles to understand and remedy problems like
HIV/AIDS, coronary heart disease, and Ebola infection. American
Plagues weaves stories of encounters with epidemics over our
history with lessons that aid our present understanding of health
and disease. Doctors and clergy, writers and newsmen, public health
institutions, and even an entire town relate their personal
experiences with various outbreaks and the ways they were
identified, contained, and treated. The stories are filled with
ambition and accomplishment, jealousy and disappointment, public
spirit and self-interest, egotism and modesty. Some episodes lead
to vital discoveries. Others were unproductive. Yet each proved
instructive and expanded our abilities to gather and process
information in ways that improve medicine and public health today.
American Plagues gives readers insights into some of the people and
events that make up our rich public health history as well as
skills to better grasp the complex health information that cascades
upon us from the media.
Cancer is a leading cause of death among adults. Although about
250f Americans develop cancer in their lifetime, in some
populations this rate has been reduced by lifestyle changes.
Increasing numbers of people are turning to the use of dietary
vegetables, medicinal herbs, and plant extracts to prevent or treat
cancer. Their ready availability as "over the counter" supplements
has contributed to an explosion in the use of herbal extracts and
related compounds for health enhancement.
The spectacular growth of the multi-billion dollar functional
food and nutraceutical business, touting health claims sometimes
based upon limited research data, underscores the need for this
up-to-date reference. "Functional Foods and Nutraceuticals in
Cancer Prevention" brings together a leading group of experts on
the different aspects of nutrient supplementation, foods, and plant
extracts in cancer prevention and treatment. Their conclusions and
recommendations present the most current knowledge from which to
springboard future research and create a scientific database for
accurate health claims.
. This up-to-date resource is a must-have for research
professionals, both basic and applied, and marketers in the
worldwide functional foods/nutritional supplements industry. It is
an essential reference for hospital-based dietitians and
nutritionists, physicians specializing in oncology, and cancer
researchers. Food and drug officials who determine allowable health
claims need this information as well, as do academics in all of
these fields
If you had a trillion dollars and a year to spend it for the good
of the world and the advancement of science, what would you do?
It's an unimaginably large sum, yet it's only around one per cent
of world GDP, and about the valuation of Google, Microsoft or
Amazon. It's a much smaller sum than the world found to bail out
its banks in 2008 or deal with Covid-19. But what could you achieve
with $1 trillion? You could solve the problem of the pandemic, for
one, and eradicate malaria, and maybe cure all disease. You could
end global poverty. You could settle on the Moon and explore the
solar system. You could build a massive particle collider to probe
the nature of reality like never before. You could build quantum
computers, develop artificial intelligence, or increase human
lifespan. You could even create a new life form. Or how about
transitioning the world to clean energy? Or preserving the
rainforests, or saving all endangered species? Maybe you could
refreeze the melting Arctic, launch a new sustainable agricultural
revolution, and reverse climate change? How to Spend a Trillion
Dollars is the ultimate thought experiment but it is also a call to
arms: these are all things we could do, if we put our minds to it -
and our money.
Genomic and Precision Medicine: Foundations, Translation, and
Implementation highlights the various points along the continuum
from health to disease where genomic information is impacting
clinical decision-making and leading to more personalization of
health care. The book pinpoints the challenges, barriers, and
solutions that have been, or are being, brought forward to enable
translation of genome based technologies into health care. A
variety of infrastructure (data systems and EMRs), policy
(regulatory, reimbursement, privacy), and research (comparative
effectiveness research, learning health system approaches)
strategies are also discussed. Readers will find this volume to be
an invaluable resource for the translational genomics and
implementation science that is required to fully realize
personalized health care.
Atlas of Mycobacterium Tuberculosis reveals in-depth information
about mycobacterium tuberculosis which has never before been
reported. Using atomic force microscopy (AFM), the in-depth
phenotypic interaction that occurs in different stages of the
tuberculosis lifecycle is illustrated, including resting,
exponential, and dormant states. Coverage also includes the
macroscopic and microscopic anatomy of mycobacterium, including
pigmentation, morphology of colonies, size and shape, and the
phenotypic changes from susceptible to resistant, all shown with
images from electronic and atomic force microscopes. This book will
open a new window into the results of molecular changes at the
cellular level, guiding researchers and scientists to think in new
ways about the area of cell wall and the reproductive and drug
resistance phenomena surrounding tuberculosis.
This book is designed to provide a comprehensive and
state-of-the-art resource for clinicians who care for patients with
sepsis and research scientist alike, . Patients with severe sepsis
requiring ICU admission have very high rates of ICU and overall
hospital mortality, with estimates ranging from 18 to 50%. Risk
factors for death from sepsis include underlying illness, increased
age, and multi-system organ failure. This is compounded by the
significant variation in the management of early severe sepsis.
Care of these patients and clinical conditions can be quite
complex, and materials are collected from the most current,
evidence-based resources. Book sections have been structured to
review the overall definitions and epidemiology of sepsis as well
as current insights into the pathophysiology of sepsis. This review
summarizes the evidence for the international consensus guidelines
for the identification and management of sepsis. The latter part of
this book reviews emerging concepts and approaches in the diagnosis
and management of sepsis that may significantly reduce mortality in
the future. Sepsis: Pathophysiology, Definitions and the Challenge
of Bedside Management represents a collaboration between authors
drawn from a variety of disciplines and contributions from basic
scientists and highly recognized clinical opinion leaders with
expertise in clinical trials.
Noncommunicable Diseases: A Compendium introduces readers to
noncommunicable diseases (NCDs) - what they are, their burden,
their determinants and how they can be prevented and controlled.
Focusing on cardiovascular disease, diabetes, cancer and chronic
respiratory disease and their five shared main risk factors
(tobacco use, harmful use of alcohol, unhealthy diet, physical
inactivity and air pollution) as defined by the United Nations,
this book provides a synopsis of one of the world's biggest
challenges of the 21st century. NCDs prematurely claim the lives of
millions of people across the world every year, with untold
suffering to hundreds of millions more, trapping many people in
poverty and curtailing economic growth and sustainable development.
While resources between and within countries largely differ, the
key principles of surveillance, prevention and management apply to
all countries, as does the need to focus resources on the most
cost-effective and affordable interventions and the need for strong
political will, sufficient resources, and sustained and broad
partnerships. This compendium consists of 59 short and accessible
chapters in six sections: (i) describing and measuring the burden
and impact of NCDs; (ii) the burden, epidemiology and priority
interventions for individual NCDs; (iii) social determinants and
risk factors for NCDs and priority interventions; (iv) global
policy; (v) cross-cutting issues; and (vi) stakeholder action.
Drawing on the expertise of a large and diverse team of
internationally renowned policy and academic experts, the book
describes the key epidemiologic features of NCDs and evidence-based
interventions in a concise manner that will be useful for
policymakers across all parts of society, as well as for public
health and clinical practitioners.
Are you tired? Achy? Depressed? Overweight? You could be suffering from an autoimmune disease. Autoimmune disease is the third major category of illness in the United States, yet very little is known about the many serious and chronic immune conditions. If you're one of the 50 million Americans suffering from one kind of autoimmune disease-whether it's lupus, rheumatoid arthritis, multiple sclerosis, thyroid disease, fibromyalgia, chronic fatigue syndrome, or Crohn's disease-there's a good chance you'll develop another. This book can help. Written by Mary J. Shomon, a well-known patient advocate who was diagnosed with autoimmune disease in 1995, this guide to alternative and natural remedies shows you how to treat the underlying causes of immune system imbalance, not just the symptoms. It contains first-person accounts from doctors, patients, and holistic practitioners, as well as checklists, quizzes, and a proposed recovery plan. In addition, it offers detailed information about: • The most common autoimmune conditions • The factors that can lead to autoimmune disease • Interpreting your symptoms • Procedures and treatments • Finding the right doctor Until we find a cure, living with autoimmune disease can be frightening and frustrating. But it doesn't have to be. This valuable guide helps you understand what may be causing the disorder and helps you take the first healthy, natural steps toward correcting it.
The international symposium "Syringomyelia 2000" in Kobe, Japan, brought together experts in neurosurgery, neurology, and neuropathology. The decade leading up to this event saw remarkable developments in surgery and imaging technology. The symposium was thus an opportunity for researchers and clinicians to enhance and broaden the scope of their knowledge and to become more aware of work being done in complementary fields. With its collection of papers presented at the Kobe conference, this volume contains a thorough and comprehensive description of syringomyelia - its classification, pathology, and pathophysiology; experimental studies; and its association with abnormalities of the craniocervical junction, Chari II malformation, tethered cord, and other disorders. This compilation provides valuable state-of-the-art information for professionals in the fields of neurosurgery, neurology, and neuropathology and for all others concerned with syringomelia.
Biotherapy is defined as the use of living organisms in the
treatment and diagnosis of human and animal diseases. This volume
is an evocative exploration of the history, scientific basis and
practical use of the major biotherapy modalities. The authors
provide researchers and practitioners interested in this field,
with cutting-edge material on the latest key advances in the
following fields of biotherapy: Maggot Therapy, Hirudotherapy, Bee
Venom Therapy, Apitherapy, Ichthyotherapy, Helminth Therapy, Phage
Therapy, Animal Assisted Therapy, Canine Olfactory Detection. In
addition, the authors provide with their chapters an extensive
bibliography that represents a state-of-the-art survey of the
literature. Comprehensive and current, this fresh volume of reviews
is an essential resource for professionals who need to stay ahead
of the game in the exciting field of biotherapy.
|
|